In one preclinical study using OVCAR-3 cell, Peluso et al. demonstrated that high PR expression in ovarian cancer cells correlated with decreased expression of PR membrane component-1 (PRMC-1), thereby enhancing cisplatin effectiveness [26]. The gene discussed is PGR; the disease is ovarian carcinoma.